Arix Bioscience Plc Director/PDMR Shareholding (1654Y)
02 Maio 2023 - 11:53AM
UK Regulatory
TIDMARIX
RNS Number : 1654Y
Arix Bioscience Plc
02 May 2023
Arix Bioscience plc
("Company")
PDMR notifications & Director Shareholdings
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
Arix Bioscience Plc has been notified of the following
transactions relating to the below named PDMRs and their respective
interests in the ordinary share capital of the Company
('Shares'):
Peregrine Moncreiffe, Non-Executive Director and Chairman of the
Board purchased 75,000 Ordinary shares of 0.001 pence each in the
Company ("Shares") on 27 April 2023 at a price of 102.5 pence per
share and purchased a further 85,000 Shares in the Company on 28
April 2023 at a price of 104.8 pence per share.
Debra Barker, Non-Executive Director and Senior Independent
Director purchased 24,000 Shares in the Company on 27 April 2023 at
a price of 103 pence per share.
Robert Lyne, Chief Executive Officer purchased 24,330 Shares in
the Company on 27 April 2023 at a price of 102.75 pence per
share.
In a separate transaction, Robert Lyne exercised vested options
over 203,764 shares ("Option Shares") on 27 April 2023 pursuant to
a nil cost share award granted on 30 June 2020. 96,107 of the
Shares were sold on 27 April 2023 at a sale price of 101.5 pence
per share to satisfy the resultant income tax and National
Insurance liability.
The notification below, made in accordance with the requirements
of UK Market Abuse Regulation, provides further detail on the
respective transactions.
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Peregrine Moncreiffe
----------------------------------------- -----------------------------------------------
Reason for the notification
2
------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director and Chair of the
Board
----------------------------------------- -----------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------- -----------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
----------------------------------------- -----------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
----------------------------------------- -----------------------------------------------
Details of the transaction(s): section to be repeated for (i)
4 each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
------------------------------------------------------------------------------------------
a) Description of the financial Arix Bioscience plc Ordinary shares of
instrument, type of instrument 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s) Price(s)GBP Volume(s)
27 April 2023 1.025 75,000
28 April 2023 1.048 85,000
------------------- ---------------
d) Aggregated information
- Aggregated volume 160,000
- Price GBP165,962.50
e) Date of the transaction 27 April 2023 28 April 2023
f) Place of the transaction Outside a trading venue
----------------------------------------- -----------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Robert Lyne
---------------------------------------- ---------------------------------------------------
Reason for the notification
2
---------------------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
---------------------------------------- ---------------------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------------------- ---------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
---------------------------------------- ---------------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---------------------------------------- ---------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
4 each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
---------------------------------------------------------------------------------------------
a) Description of the Arix Bioscience plc Ordinary shares of 0.001
financial instrument, pence each
type of instrument
Identification code GB00BD045071
b) Nature of the transaction Share Purchase
---- ---------------------------------------- ---------------------------------------------------
c) Price(s) and volume(s) Price(s)GBP Volume(s)
---------------------------------------- --------------------------- -------------------
GBP1.0275 24,330
------------------------------------------------------------------------- -------------------
d) Aggregated information
- Aggregated volume N/A (Single Transaction)
- Price GBP24,999.08
e) Date of the transaction 27 April 2023
f) Place of the transaction London Stock Exchange
---------------------------------------- ---------------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Robert Lyne
---------------------------- --------------------------------------------------------
Reason for the notification
2
--------------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
---------------------------- --------------------------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------- --------------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
---------------------------- --------------------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---------------------------- --------------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
4 each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
--------------------------------------------------------------------------------------
a) Description of the Arix Bioscience plc Ordinary shares of 0.001
financial instrument, pence each
type of instrument
Identification code GB00BD045071
b) Nature of the transaction Vesting of awards under the Company's Executive
Incentive Plan ("EIP") 2020 and sale of shares
to cover associated tax liabilities
---- ---------------------------- --------------------------------------------------------
c) Price(s) and volume(s) Price(s)GBP Volume(s)
---------------------------- ----- --------------------------------- ----------
1.) Acquisition
GBPnil per share 203,764
2.) Disposal GBP1.015 96,107
------------------------------------------------------------------------- ----------
d) Aggregated information
- Aggregated volume N/A (Single Transaction)
- Price GBP97,548.61
e) Date of the transaction 27 April 2023
f) Place of the transaction Outside a trading venue
---------------------------- --------------------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Debra Barker
--------------------------------------- ---------------------------------------------
Reason for the notification
2
--------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
--------------------------------------- ---------------------------------------------
b) Initial notification /Amendment Initial Notification
--------------------------------------- ---------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Arix Bioscience plc
--------------------------------------- ---------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
--------------------------------------- ---------------------------------------------
Details of the transaction(s): section to be repeated for (i)
4 each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
--------------------------------------------------------------------------------------
a) Description of the financial Arix Bioscience plc Ordinary shares of
instrument, type of instrument 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s) Price(s) GBP Volume(s)
GBP1.03.00 24,000
d) Aggregated information
- Aggregated volume N/A (single transaction)
- Price GBP24,720.00
e) Date of the transaction 27 April 2023
f) Place of the transaction London Stock Exchange
--------------------------------------- ---------------------------------------------
Ends.
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHZLLFBXELEBBF
(END) Dow Jones Newswires
May 02, 2023 10:53 ET (14:53 GMT)
Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
